Graves’ Disease Plasma
About: Graves' Disease Plasma - Cryopreserved human plasma collected from clinically confirmed Graves' Disease donors. Graves' Disease plasma is ideal for cytokine analysis, metabolic profiling, and immune-related biomarker discovery.
| Lot Number | Condition | Volume | Race/Ethnicity | Age | Gender | Country of Collection | Medications | Vials | Price | Action |
|---|---|---|---|---|---|---|---|---|---|---|
| 69460 | Graves' Disease | 1.0 ML | Asian/Pacific Islander | 26 | Female |
methamisol 2.25 mg 5 days a week
|
16 | $495.00 | ||
| 70526 | Graves' Disease | 1.0 ML | Native American | 63 | Male | 16 | $495.00 | |||
| 73325 | Graves' Disease | 1.0 ML | Hispanic/Latino | 38 | Female | United States (US) |
levothyroxine 125mcg QD
|
15 | $495.00 | |
| 71781 | Graves' Disease | 1.0 ML | Asian/Pacific Islander | 38 | Male | United States (US) |
Methimazole 5mg QD; QVAR 80mcg/2xday; Propranolol 10mg QD
|
9 | $495.00 | |
| 69442 | Graves' Disease | 1.0 ML | Caucasian | 44 | Female | United States (US) |
Methimazole 10mg daily, other supplements Methimazole, 5mg, QD Iron, 65mg QD Vitamin D3, 5000 U, QD Pro-Air, PID Vitamin B-12, QD Albuterol Inh PRN busparone 10mg QD
|
14 | $495.00 | |
| 69353 | Graves' Disease | 1.0 ML | African American | 60 | Female | United States (US) |
Vitamins, C, E, D, biotin, selenium, velafaxine 150mg and 75mg, Meloxicam, methamazol, metoprolol, atorvastatin, buspar Adorvastin Venlofaxin Metropolol
|
16 | $495.00 | |
| 69291 | Graves' Disease | 1.0 ML | Asian/Pacific Islander | 66 | Male | United States (US) |
No medications
|
8 | $495.00 | |
| 69382 | Graves' Disease | 1.0 ML | Caucasian | 63 | Female | United States (US) |
Levothyroxine, liothyronine. Temazapam Levothyroxine 88 mcg QD Liothyronine 5 mcg QD Hizentra 12gm/60 ml Infusion QD
|
16 | $495.00 | |
| 68848 | Graves' Disease | 1.0 ML | Native American | 63 | Male | United States (US) | 14 | $495.00 |
Graves’ Disease Plasma | High-Quality Human Plasma from Graves’ Disease Donors
Graves’ Disease Plasma is collected from donors clinically diagnosed with Graves’ Disease and processed within hours of collection to preserve key analytes such as cytokines, proteins, and metabolites. This human plasma supports research focused on inflammatory pathways, immune profiling, and biomarker discovery in Graves’ Disease pathophysiology.
Product Features
- Research Use Only (RUO)
- Plasma collected from clinically confirmed Graves’ Disease donors
- Processed within one day of collection
- IRB-approved protocols and informed consent
- Custom aliquot volumes available upon request
De-identified Donor Data
- Verified Graves’ Disease diagnosis
- Demographic data: age, sex assigned at birth, race/ethnicity
- Donor-reported medications, allergies, and comorbidities
- Additional Graves’ Disease-specific metadata available
Applications
- Biomarker discovery and validation
- Cytokine and inflammation profiling
- Metabolomics and proteomics studies
- Therapeutic response research
Compliance and Quality Assurance
- IRB-approved and HIPAA-compliant protocols
- Electronic informed consent with 21 CFR Part 11 – compliant e-signatures
- Documentation support available for regulatory review
Ordering and Customization
Graves’ Disease plasma is available in standard and custom volumes. For international orders or documentation requirements, please email learnmore@sanguinebio.com to ensure compatibility with your country’s regulations.
Protocols & Documentation
-
Download
Plasma Isolation
Protocol for plasma separation from anticoagulated whole blood, including processing, storage, and traceability requirements.
-
Informed Consent Form (ICF)
Available upon request — confirms donor consent for research use and downstream commercialization.
Plasma
Frequently Asked Questions
1 Answer
YES – All collections are conducted under IRB-approved protocols and electronic informed consent. Sanguine utilizes Advarra and WCG IRB for oversight.
1 Answer
YES – with the exception of GMP leukopaks, all our products are research use only (RUO).
1 Answer
Our complete catalog can be found here: https://sanguinebio.com/products/
1 Answer
Storage depends on sample type but often cryopreserved samples stored in liquid nitrogen can be stored for years.
1 Answer
Extensive customization is available. To discuss your project request a quote or email us at learnmore@sanguinebio.com.
1 Answer
Sanguine offers flexible prospective colleciton services to tailored to fit your research. For more information and request a quote, please see: https://sanguinebio.com/prospective-biospecimen-collection-services/
1 Answer
Timelines depend on condition, sample type, and I/E criteria but we often start collection within 2 weeks of signed agreement.
1 Answer
YES – we have in-stock inventory which can be found here https://sanguinebio.com/products/?pro_inventory=inventory. You can also email us at learnmore@sanguinebio.com as we continually get new samples in our inventory.
1 Answer
Each sample from a different individual – Unique donor means each sample comes from a different person, ensuring biological diversity in your study.
1 Answer
YES – Unique donors can be specified and guaranteed based on your requirements.
1 Answer
For information about sample quality, please see: https://sanguinebio.com/quality-and-compliance/
1 Answer
YES – “IRB-approved collection protocols” and IRB approval documentation available upon request. Sanguine utilizes two internationally-recognized IRBs (Advarra and WCG IRB) for review and approval.
Ask a Question
Need a custom Plasma cohort?
Our scientific team can scope prospective collections with donor-specific I/E criteria, typically starting within 2 weeks of agreement.